Cognition Therapeutics Inc
CGTX
Get informed when a big investor buys or sells
+ FollowMarket Cap$96.66M
Close$
$0.50
52.2% downside
Current Fair Value
52.2% downsideOvervalued by 52.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $96.66 Million |
|---|---|
| Enterprise Value | $63.93 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.32 |
| Beta | 1.75 |
| Outstanding Shares | 90,624,381 |
Return
| Return on Equity | -25.05% |
|---|---|
| Return on Assets | -21.27% |
| Return on Invested Capital | -109.43% |
Valuation & Multiples
| P/E Ratio | -5.63 |
|---|---|
| PEG | 5.63 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.75 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$5.00 M
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.07
Average shareholder expectationRevenue Estimate
$5.30 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 8.16%▼ 15.85% |
|---|---|
| Total Invested | $8.37M▼ 48.60% |
| Investors Holding | 25▼ 50.00% |
ESG Score
No data